Wednesday, March 27, 2019

The Use of Recombinant DNA :: Papers

The Use of Recombinant desoxyribonucleic acid I agree that recombinant deoxyribonucleic acid benefits humans only to a certain extent though. During the late mid-sixties and early 1970s a series of independent discoveries made in rapid succession yielded a new technology whereby humans bring in the capability to manipulate and direct the very evolution of life itself. This is fulfill through the process of cistron splicing (Recombinant DNA). There are quartet essential elements of the process a method of breaking and joining DNA molecules from different sources, a gene carrier that flush toilet replicate some(prenominal) itself and the foreign DNA, a means of introducing the foreign DNA into a lendable bacteria cell, and a method of selecting from a large population the cells which necessitate the foreign DNA. Using procedures like recombinant DNA, many human genes have been cloned in E. coli or in yeast. This was made possible for the first tim e to fix unlimited amounts of human proteins. Cultured cells (E. coli, yeast, mammalian cells) transformed with the human gene are being used to manufacture insulin for diabetics, human growth endocrine (GH) GH from domestic mammals like cows and pigs does not work in humans. So for many years, the only source of GH for therapy was that taken out from the glands of human cadavers. just this supply was shut off when several patients died from a rare neurological disease attributed to contaminated glands. Now, thanks to recombinant DNA technology, recombinant human GH is available. While a great benefit to patients suffering form GH wish, there has also been printing press to use it to stimulate growth in youngsters who have no deficiency but whose parents want them to grow up tall, erythropoietin (EPO) People with failing kidneys can be kept alive by dialysis. But dialysis only cleanses the personal line of credit of wastes. Without a source of EPO, th ese patients suffer from anaemia. Now, thanks to recombinant DNA technology, recombinant human EPO is available to treat these patients, for treating anaemia, tissue plasminogen activator (TPA) for dissolving blood clots, angiostatin and endostatin for trials as anti-cancer

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.